Rheumatology

New research presented at ACR 2025 shows GLP-1 receptor agonists, used for diabetes and obesity, may reduce rheumatoid arthritis flares and inflammation.

New research presented at ACR 2025 reveals IL-6 and CCL3 as predictive markers of fetal heart block in anti-Ro–positive pregnancies, paving the way for early detection and prevention.

Thrombotic events remain a major driver of mortality and morbidity among patients with systemic lupus erythematosus.

Tumor necrosis factor inhibitor therapy in patients with psoriatic arthritis does not appear to accelerate weight gain beyond expected age-related trends, according to findings from a retrospective cohort study.

Cross-sectional testing shows reduced cardiorespiratory fitness in psoriatic arthritis, with disease activity and adiposity linked to lower VO2peak and self-reported activity linked to higher fitness.

JAK inhibition with tofacitinib increased lower limb muscle volume; strength and function did not improve in rheumatoid arthritis.

Advanced drug delivery systems may improve outcomes in gout and hyperuricemia by enhancing targeting and tolerability.

Adrenal crisis was rare after glucocorticoid taper in children with nephrotic syndrome or juvenile idiopathic arthritis.